Beam Therapeutics vs CRISPR Therapeutics
Beam Therapeutics vs CRISPR Therapeutics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Beam Therapeutics is on 47/100 and CRISPR Therapeutics on 64/100.
Where each one leads
Beam Therapeutics
Leads on none of the measures we hold for both companies.
CRISPR Therapeutics
- our overall score: 64/100 against 47/100
- domain rating: 67/100 against 0/100
- funding raised: $547M against $235M
At a glance
| Measure | Beam Therapeutics | CRISPR Therapeutics |
|---|---|---|
| What it is | A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases. | Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology. |
| Category | Workflows, Biotech, MedTech, Genomics | Biotechnology, Gene Editing, Therapeutics, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2013 |
| Headquarters | Cambridge, United States | Zug, Switzerland |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Beam Therapeutics | CRISPR Therapeutics |
|---|---|---|
| Total funding | $235M | $547M |
| Latest round | Series C | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Beam Therapeutics | CRISPR Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 47/100 | 64/100 |
| Traction | 40/100 | 40/100 |
| Team | Not published | 70/100 |
| Search visibility | 2/100 | 13/100 |
| Quality | 68/100 | 88/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | D (44/100) |
| Domain ratingLink authority, 0-100 | 0/100 | 67/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Beam Therapeutics | CRISPR Therapeutics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
Beam Therapeutics vs CRISPR Therapeutics: common questions
Which is better, Beam Therapeutics or CRISPR Therapeutics?
On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 47/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Beam Therapeutics and CRISPR Therapeutics compare on the numbers?
CRISPR Therapeutics leads on our overall score (64/100 against 47/100), domain rating (67/100 against 0/100), funding raised ($547M against $235M).
Read the full Beam Therapeutics review and pricing or the CRISPR Therapeutics review and pricing. You can also browse other Beam Therapeutics alternatives we track.